0.4844
Schlusskurs vom Vortag:
$0.4685
Offen:
$0.46
24-Stunden-Volumen:
462.52K
Relative Volume:
0.27
Marktkapitalisierung:
$22.81M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-52.41M
KGV:
-0.5323
EPS:
-0.91
Netto-Cashflow:
$-31.25M
1W Leistung:
-3.06%
1M Leistung:
-3.04%
6M Leistung:
-60.62%
1J Leistung:
-84.77%
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RANI
Rani Therapeutics Holdings Inc
|
0.4844 | 22.44M | 1.20M | -52.41M | -31.25M | -0.91 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
2024-06-14 | Eingeleitet | Maxim Group | Buy |
2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
2023-04-17 | Fortgesetzt | BTIG Research | Buy |
2022-10-11 | Eingeleitet | UBS | Buy |
2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Tools to assess Rani Therapeutics Holdings Inc.’s risk profilePortfolio Performance Report & Stock Market Timing Techniques - newser.com
How to manage a losing position in Rani Therapeutics Holdings Inc.July 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
Long term hold vs stop loss in Rani Therapeutics Holdings Inc.Weekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.Gap Up & Free Technical Confirmation Trade Alerts - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Multi asset correlation models including Rani Therapeutics Holdings Inc.Insider Buying & Verified Entry Point Detection - newser.com
Custom watchlist performance reports with Rani Therapeutics Holdings Inc.Stop Loss & Weekly Sector Rotation Insights - newser.com
Is Rani Therapeutics Holdings Inc. forming a reversal patternShare Buyback & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-09 03:36:21 - newser.com
Candlestick signals on Rani Therapeutics Holdings Inc. stock todayGold Moves & Detailed Earnings Play Alerts - newser.com
Price momentum metrics for Rani Therapeutics Holdings Inc. explainedShare Buyback & Daily Volume Surge Trade Alerts - newser.com
What drives Rani Therapeutics Holdings Inc stock priceMarket Rumors and News & Exceptional Profit Growth Tips - earlytimes.in
What analysts say about Rani Therapeutics Holdings Inc stockUtilities Sector Analysis & Access Powerful Market Insights - earlytimes.in
Is Rani Therapeutics Holdings Inc. stock affected by interest rate hikesJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Why Rani Therapeutics Holdings Inc. stock could outperform in 2025July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Price action breakdown for Rani Therapeutics Holdings Inc.July 2025 Retail & Safe Swing Trade Setups - newser.com
Building trade automation scripts for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):